Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial
Open Access
- 30 April 2010
- journal article
- research article
- Published by Elsevier in Journal of Lipid Research
- Vol. 51 (4) , 755-762
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and/or simvastatin in menJournal of Lipid Research, 2009
- Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markersJournal of Lipid Research, 2009
- Baseline plasma plant sterol concentrations do not predict changes in serum lipids, C-reactive protein (CRP) and plasma plant sterols following intake of a plant sterol-enriched foodEuropean Journal of Clinical Nutrition, 2007
- Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe–statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemiaCurrent Medical Research and Opinion, 2007
- Basal plasma concentrations of plant sterols can predict LDL-C response to sitosterol in patients with familial hypercholesterolemiaEuropean Journal of Clinical Nutrition, 2007
- Plasma Concentrations of Plant Sterols: Physiology and Relationship with Coronary Heart DiseaseNutrition Reviews, 2006
- Cholestanol: A serum marker to guide LDL cholesterol-lowering therapyAtherosclerosis, 2006
- Effect of Statins on Noncholesterol Sterol Levels: Implications for Use of Plant Stanols and SterolsThe American Journal of Cardiology, 2005
- Why some patients respond poorly to statins and how this might be remediedEuropean Heart Journal, 2002
- Apolipoprotein E phenotype and cholesterol metabolism in familial hypercholesterolemiaAtherosclerosis, 1989